Clinical Trial Update: Neoadjuvant Platinum-based Chemoradiation Therapy for Locally Advanced Triple Negative Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 neoadjuvant trial of platinum-based chemoradiation for locally advanced triple-negative breast cancer was terminated, with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Snippet

Sponsor: Washington University School of Medicine | Conditions: Breast Neoplasms | Phase 2 | Status: TERMINATED | Results posted: 2016-10-28